Sequent Scientific plans to sell Specialty Chemicals Division

The Bangalore-based Sequent Scientific Ltd, a fully integrated pharmaceutical company, has informed BSE that the Board of Directors of the company has approved the transfer of Specialty Chemicals Division along with all related assets and liabilities of the company by way of slump sale to any company/entity/or any other person.
 
The above said transfer is subject to the approval of the shareholders of the company.
 
SeQuent, which has a presence in different pharmaceutical verticals as well as specialty chemicals, recently signed an joint venture agreement with the Chennai based Shasun Pharmaceuticals to develop, manufacture and sell veterinary products including active pharmaceutical ingredients (APIs) and formulations in the global market.